Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 4.858.759.5238.6721.19

What is the latest EV/Core EBITDA ratio of NATCO PHARMA ?

The latest EV/Core EBITDA ratio of NATCO PHARMA is 4.85 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20254.85
Mar20248.75
Mar20239.52
Mar202238.67
Mar202121.19

How is EV/Core EBITDA of NATCO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 4.85
-44.57
Mar2024 8.75
-8.09
Mar2023 9.52
-75.38
Mar2022 38.67
82.49
Mar2021 21.19 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Core EBITDA ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,097.5 Cr -3.7% 11.9% -34.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,753.0 Cr -0.2% 6.1% 0.3% Stock Analytics
DIVIS LABORATORIES ₹167,998.0 Cr -1.4% -4.9% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,186.0 Cr 0.8% 5% 12.9% Stock Analytics
CIPLA ₹120,960.0 Cr -1.3% -0.5% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,759.0 Cr -0.7% 5.1% 4.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-3.7%

11.9%

-34.8%

SENSEX

-0.6%

2.2%

5.3%


You may also like the below Video Courses